62 related articles for article (PubMed ID: 22343098)
1. Protein kinase activity profiling of postmortem human brain tissue.
Hoozemans JJ; Hilhorst R; Ruijtenbeek R; Rozemuller AJ; van der Vies SM
Neurodegener Dis; 2012; 10(1-4):46-8. PubMed ID: 22343098
[TBL] [Abstract][Full Text] [Related]
2. Profiling of the renal kinome: a novel tool to identify protein kinases involved in angiotensin II-dependent hypertensive renal damage.
de Borst MH; Diks SH; Bolbrinker J; Schellings MW; van Dalen MB; Peppelenbosch MP; Kreutz R; Pinto YM; Navis G; van Goor H
Am J Physiol Renal Physiol; 2007 Jul; 293(1):F428-37. PubMed ID: 17429032
[TBL] [Abstract][Full Text] [Related]
3. Protein Kinase Activity Decreases with Higher Braak Stages of Alzheimer's Disease Pathology.
Rosenberger AF; Hilhorst R; Coart E; García Barrado L; Naji F; Rozemuller AJ; van der Flier WM; Scheltens P; Hoozemans JJ; van der Vies SM
J Alzheimers Dis; 2016; 49(4):927-43. PubMed ID: 26519433
[TBL] [Abstract][Full Text] [Related]
4. Mitogen- and stress-activated protein kinase 1: convergence of the ERK and p38 pathways in Alzheimer's disease.
Webber KM; Smith MA; Lee HG; Harris PL; Moreira P; Perry G; Zhu X
J Neurosci Res; 2005 Feb; 79(4):554-60. PubMed ID: 15635602
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of protein kinase activities of cell lysates using peptide microarrays based on surface plasmon resonance imaging.
Mori T; Inamori K; Inoue Y; Han X; Yamanouchi G; Niidome T; Katayama Y
Anal Biochem; 2008 Apr; 375(2):223-31. PubMed ID: 18191030
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C anchoring deficit in postmortem brains of Alzheimer's disease patients.
Battaini F; Pascale A; Lucchi L; Pasinetti GM; Govoni S
Exp Neurol; 1999 Oct; 159(2):559-64. PubMed ID: 10506528
[TBL] [Abstract][Full Text] [Related]
7. A peptide microarray for detecting protein kinase activity in cell lysates.
Han X; Katayama Y
Methods Mol Biol; 2010; 669():183-94. PubMed ID: 20857367
[TBL] [Abstract][Full Text] [Related]
8. Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease.
Ho L; Qin W; Pompl PN; Xiang Z; Wang J; Zhao Z; Peng Y; Cambareri G; Rocher A; Mobbs CV; Hof PR; Pasinetti GM
FASEB J; 2004 May; 18(7):902-4. PubMed ID: 15033922
[TBL] [Abstract][Full Text] [Related]
9. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF
Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749
[TBL] [Abstract][Full Text] [Related]
10. Site-specific phosphorylation profiling of Arabidopsis proteins by mass spectrometry and peptide chip analysis.
de la Fuente van Bentem S; Anrather D; Dohnal I; Roitinger E; Csaszar E; Joore J; Buijnink J; Carreri A; Forzani C; Lorkovic ZJ; Barta A; Lecourieux D; Verhounig A; Jonak C; Hirt H
J Proteome Res; 2008 Jun; 7(6):2458-70. PubMed ID: 18433157
[TBL] [Abstract][Full Text] [Related]
11. Monitoring protein kinase activity in cell lysates using a high-density peptide microarray.
Han X; Yamanouchi G; Mori T; Kang JH; Niidome T; Katayama Y
J Biomol Screen; 2009 Mar; 14(3):256-62. PubMed ID: 19211777
[TBL] [Abstract][Full Text] [Related]
12. Zinc transporter mRNA levels in Alzheimer's disease postmortem brain.
Beyer N; Coulson DT; Heggarty S; Ravid R; Hellemans J; Irvine GB; Johnston JA
J Alzheimers Dis; 2012; 29(4):863-73. PubMed ID: 22349685
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling and functional proteomic analysis reveal perturbed kinase-mediated signaling in genetic stroke susceptibility.
Fornage M; Swank MW; Boerwinkle E; Doris PA
Physiol Genomics; 2003 Sep; 15(1):75-83. PubMed ID: 12902546
[TBL] [Abstract][Full Text] [Related]
14. Array-based fluorescence assay for serine/threonine kinases using specific chemical reaction.
Akita S; Umezawa N; Kato N; Higuchi T
Bioorg Med Chem; 2008 Aug; 16(16):7788-94. PubMed ID: 18656369
[TBL] [Abstract][Full Text] [Related]
15. The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimer's disease.
Glatz DC; Rujescu D; Tang Y; Berendt FJ; Hartmann AM; Faltraco F; Rosenberg C; Hulette C; Jellinger K; Hampel H; Riederer P; Möller HJ; Andreadis A; Henkel K; Stamm S
J Neurochem; 2006 Feb; 96(3):635-44. PubMed ID: 16371011
[TBL] [Abstract][Full Text] [Related]
16. Caffeine induces beneficial changes in PKA signaling and JNK and ERK activities in the striatum and cortex of Alzheimer's transgenic mice.
Zeitlin R; Patel S; Burgess S; Arendash GW; Echeverria V
Brain Res; 2011 Oct; 1417():127-36. PubMed ID: 21907331
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling.
Colangelo V; Schurr J; Ball MJ; Pelaez RP; Bazan NG; Lukiw WJ
J Neurosci Res; 2002 Nov; 70(3):462-73. PubMed ID: 12391607
[TBL] [Abstract][Full Text] [Related]
18. Disrupted muscarinic M1 receptor signaling correlates with loss of protein kinase C activity and glutamatergic deficit in Alzheimer's disease.
Tsang SW; Pomakian J; Marshall GA; Vinters HV; Cummings JL; Chen CP; Wong PT; Lai MK
Neurobiol Aging; 2007 Sep; 28(9):1381-7. PubMed ID: 16828202
[TBL] [Abstract][Full Text] [Related]
19. Rapid increase of the human IFN-gamma receptor phosphorylation in response to human IFN-gamma and phorbol myristate acetate. Involvement of different serine/threonine kinases.
Mao C; Merlin G; Ballotti R; Metzler M; Aguet M
J Immunol; 1990 Dec; 145(12):4257-64. PubMed ID: 2147939
[TBL] [Abstract][Full Text] [Related]
20. Characterization and differential distribution of the three major human protein kinase C isozymes (PKC alpha, PKC beta, and PKC gamma) of the central nervous system in normal and Alzheimer's disease brains.
Clark EA; Leach KL; Trojanowski JQ; Lee VM
Lab Invest; 1991 Jan; 64(1):35-44. PubMed ID: 1990207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
